SEC Filing Details

Our enduring purpose: to fundamentally improve the lives of patients with serious diseases in ways never before possible.

SEC Filing Details

Document Details

Form
Filing Date
Dec 26, 2019
Document Date
Dec 19, 2019
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.